|
ZDHHC5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.0320999983301E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.40720000096906E-08 |
| Normal-vs-Stage2 |
1.083860E-03 |
| Normal-vs-Stage3 |
4.175700E-04 |
| Normal-vs-Stage4 |
5.63279999999944E-05 |
| Stage1-vs-Stage2 |
7.452000E-01 |
| Stage1-vs-Stage3 |
7.112100E-02 |
| Stage1-vs-Stage4 |
6.130000E-01 |
| Stage2-vs-Stage3 |
3.948200E-01 |
| Stage2-vs-Stage4 |
9.108600E-01 |
| Stage3-vs-Stage4 |
4.064600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.2358999963763E-08 |
| Normal-vs-AfricanAmerican |
1.809890E-04 |
| Normal-vs-Asian |
7.85870000000743E-05 |
| Caucasian-vs-AfricanAmerican |
6.658200E-01 |
| Caucasian-vs-Asian |
9.074200E-01 |
| AfricanAmerican-vs-Asian |
6.169400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.76979999999949E-05 |
| Normal-vs-Female |
1.84299999705928E-08 |
| Male-vs-Female |
2.633800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.69069996786209E-09 |
| Normal-vs-Age(41-60Yrs) |
1.71719999997322E-06 |
| Normal-vs-Age(61-80Yrs) |
3.804900E-04 |
| Normal-vs-Age(81-100Yrs) |
8.354800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.628400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.832200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.694400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.066200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.723800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.731970E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.696400E-01 |
| Classical-VS-Follicular |
3.196200E-03 |
| Classical-VS-Other |
8.692000E-01 |
| Classical-VS-Normal |
1.7901999882497E-09 |
| Tall-VS-Follicular |
3.791500E-02 |
| Tall-VS-Other |
8.823400E-01 |
| Tall-VS-Normal |
2.27090000000096E-05 |
| Follicular-VS-Other |
2.797400E-01 |
| Follicular-VS-Normal |
1.484010E-02 |
| Other-VS-Normal |
7.015700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63139999999062E-05 |
| Normal-vs-N1 |
6.775000E-04 |
| N0-vs-N1 |
9.176800E-01 |
|
|
